financetom
Business
financetom
/
Business
/
Lendway Shares Jump Nearly 20% After Hours — Here's Why
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lendway Shares Jump Nearly 20% After Hours — Here's Why
Nov 21, 2025 1:16 AM

Lendway Inc. ( LDWY ) rose 19.88% to $4.10 in after-hours trading on Thursday.

Check out the current price of LDWY stock here.

The stock closed Thursday's regular session down 3.11% at $3.42, according to Benzinga Pro data.

Certificate Filed With Delaware

The finance company filed a Certificate of Amendment with Delaware's Secretary of State on Wednesday, increasing its authorized common stock from 5.71 million shares to 10 million, according to a Form 8-K filing.

The common stock has a par value of $0.01 per share.

See Also: Why Shuttle Pharmaceuticals (SHPH) Stock Surged Overnight?

The amendment became effective immediately.

Stockholders Approve Proposal

According to the filing, there were 1.17 million votes in favor of the authorized share increase, 223,490 against it, and 5,241 abstentions.

On Sep. 26, the Board passed resolutions authorizing the increase.

Annual Meeting Results

In the Annual Meeting on the same day, six nominees were chosen to be directors for a one-year term, or until their successors are chosen.

Chief Financial Officer (CFO) Elizabeth E. McShane signed the filing on Thursday.

Stock Performance

The stock is down 26.92% year to date, with an annual trading range of $3.37 to $6.19 and a market capitalization of $6.05 million.

Benzinga’s Edge Stock Rankings indicate that LDWY has a negative price trend across all time frames. Here is how the stock fares on other parameters.

Read Next:

Nuvve Holding (NVVE) Stock Surges 77% After Hours — Here’s Why It’s Trending Tonight

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved